Arvaya Healthcare Advances Rs 210 Crore Rights Issue Plan

The company has approved the Draft Letter of Offer for a rights issue up to Rs 210 crore.
Shareholders will participate in a postal ballot to provide final approvals for the capital raise.

Reader Takeaway: The move accelerates capital infusion plans; investors should now watch for the critical rights entitlement ratio.

What just happened

In a board meeting held on November 4, 2026, Arvaya Healthcare Ltd officially adopted the Draft Letter of Offer (DLOF) regarding its proposed rights issue. This milestone follows the preliminary board approval granted on July 11, 2026. The company intends to raise as much as Rs 210 crore through the issuance of partly paid-up equity shares to existing eligible shareholders.

Why this matters

For existing shareholders, the rights issue represents a potential opportunity to maintain or increase their stake in the company. However, it also introduces a capital commitment requirement. Because the issue involves partly paid-up shares, the total cost and the timing of subsequent calls will be critical for investors to evaluate their participation strategy.

What changes now

The board has initiated the process for shareholder approval via postal ballot and remote e-voting. National Securities Depository Limited (NSDL) has been appointed to manage the e-voting process, with CS Chinmay Mohan Lele serving as the scrutinizer. This step is a prerequisite to moving forward with the issuance under the Companies Act, 2013.

What to track next

The company has not yet finalized several key metrics: the issue price, the specific rights entitlement ratio, the application payment amount, and the record date. These details will be determined by the board or a dedicated Rights Issue Committee and disclosed to the stock exchange in upcoming filings.